We acknowledge that the relative low prevalence of patients with CD4+ T‐lymphocyte count <200 cells/mm3 and individuals with type 2 diabetes in the presence study sample should be taken into account when interpreting these results. The gene discussed is CD4; the disease is type 2 diabetes mellitus.